Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 11/20/25 → 4/27/33 |
Funding
- Novartis (domestic): $2.00
26-LUN-150-NP-PMC (CDJI136A12101): A Phase I/II Open Label Study of DJI136, a DLL3-Targeted CAR-T Therapy, in Adult Patients with ES-SCLC
- Hao, Zhonglin (PI)